WallStreetZen

NYSE: LLY
ELI LILLY & Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LLY past earnings growth

How has LLY's earnings growth performed historically?
Company
10.54%
Industry
14.79%
Market
102.72%
LLY's earnings have grown faster (25.1% per year) than the US Drug Manufacturers - General industry average (14.81%)
Performance
LLY's earnings have grown slower (25.1% per year) than the US market average (27.52%)
Performance
LLY's earnings growth is slowing down - its growth over the last year (10.54%) is below its 5-year compound annual rate (25.1%)
Performance

LLY past revenue growth

How has LLY's revenue growth performed historically?
Company
10.39%
Industry
13.32%
Market
36.32%
LLY's revenue has grown slower (4.78% per year) than the US Drug Manufacturers - General industry average (5.13%)
Performance
LLY's revenue has grown slower (4.78% per year) than the US market average (17.66%)
Performance
LLY's revenue growth is accelerating - its growth over the last year (10.39%) is above its 5-year compound annual rate (4.78%)
Performance

LLY earnings and revenue history

Current Revenue
$25.5B
Current Earnings
$6.1B
Current Profit Margin
23.9%
LLY's has not demonstrated consistent long-term earnings growth over the past 10 years (52.5%)
Performance

LLY Return on equity

Current Company
113.6%
Current Industry
31.9%
Current Market
30.7%
LLY's Return on Equity (113.6%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

LLY Return on assets

Current Company
13.6%
Current Industry
6.8%
Current Market
6.4%
LLY is generating higher Return on Assets (13.6%) than the US Drug Manufacturers - General industry average (7.27%)
Performance

LLY Return on capital employed

Current Company
20%
Current Industry
11.3%
LLY has gotten more efficient at generating Return on Capital (20%) compared to 3 years ago (10.8%)
Performance

LLY earnings dates

Next earnings date
Aug 3, 2021

ELI LILLY & Earnings & Revenue FAQ

What were LLY's earnings last quarter?

On Apr 27, 2021, ELI LILLY & (NYSE: LLY) reported Q1 2021 earnings per share (EPS) of $1.49, up 6.88% year over year. Total ELI LILLY & earnings for the quarter were $1.36 billion. In the same quarter last year, ELI LILLY &'s earnings per share (EPS) was $1.60.

What was LLY's earnings growth in the past year?

As of Q3 2021, ELI LILLY &'s earnings has grown 10.54% year over year. This is 4.25 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 14.79%. ELI LILLY &'s earnings in the past year totalled $6.09 billion.

What is LLY's earnings date?

ELI LILLY &'s earnings date is Aug 03, 2021. Add LLY to your watchlist to be reminded of LLY's next earnings announcement.

What was LLY's revenue last quarter?

On Apr 27, 2021, ELI LILLY & (NYSE: LLY) reported Q1 2021 revenue of $6.81 billion up 16.14% year over year. In the same quarter last year, ELI LILLY &'s revenue was $5.86 billion.

What was LLY's revenue growth in the past year?

As of Q3 2021, ELI LILLY &'s revenue has grown 10.39% year over year. This is 2.93 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 13.32%. ELI LILLY &'s revenue in the past year totalled $25.49 billion.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.